nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR2A—epilepsy syndrome	0.252	1	CbGaD
Methylergometrine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0276	0.0879	CbGbCtD
Methylergometrine—CYP3A4—Felbamate—epilepsy syndrome	0.0257	0.0817	CbGbCtD
Methylergometrine—CYP3A4—Trimethadione—epilepsy syndrome	0.0257	0.0817	CbGbCtD
Methylergometrine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0241	0.0768	CbGbCtD
Methylergometrine—CYP3A4—Clonazepam—epilepsy syndrome	0.0218	0.0695	CbGbCtD
Methylergometrine—CYP3A4—Clobazam—epilepsy syndrome	0.0209	0.0666	CbGbCtD
Methylergometrine—CYP3A4—Rufinamide—epilepsy syndrome	0.0178	0.0566	CbGbCtD
Methylergometrine—CYP3A4—Carbamazepine—epilepsy syndrome	0.0173	0.0552	CbGbCtD
Methylergometrine—CYP3A4—Primidone—epilepsy syndrome	0.0162	0.0515	CbGbCtD
Methylergometrine—CYP3A4—Phenytoin—epilepsy syndrome	0.0156	0.0495	CbGbCtD
Methylergometrine—CYP3A4—Propofol—epilepsy syndrome	0.0145	0.0462	CbGbCtD
Methylergometrine—CYP3A4—Acetazolamide—epilepsy syndrome	0.0139	0.0441	CbGbCtD
Methylergometrine—CYP3A4—Phenobarbital—epilepsy syndrome	0.0139	0.0441	CbGbCtD
Methylergometrine—CYP3A4—Midazolam—epilepsy syndrome	0.0137	0.0435	CbGbCtD
Methylergometrine—CYP3A4—Diazepam—epilepsy syndrome	0.0131	0.0418	CbGbCtD
Methylergometrine—CYP3A4—Zonisamide—epilepsy syndrome	0.0128	0.0408	CbGbCtD
Methylergometrine—CYP3A4—Valproic Acid—epilepsy syndrome	0.0104	0.033	CbGbCtD
Methylergometrine—CYP3A4—Topiramate—epilepsy syndrome	0.00935	0.0297	CbGbCtD
Methylergometrine—HTR2A—phrenic nerve—epilepsy syndrome	0.00923	0.0988	CbGeAlD
Methylergometrine—HTR1F—ganglion—epilepsy syndrome	0.00617	0.0661	CbGeAlD
Methylergometrine—DRD1—telencephalic ventricle—epilepsy syndrome	0.00501	0.0537	CbGeAlD
Methylergometrine—HTR2A—locus ceruleus—epilepsy syndrome	0.00412	0.0441	CbGeAlD
Methylergometrine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.0039	0.0417	CbGeAlD
Methylergometrine—HTR2A—cerebellar cortex—epilepsy syndrome	0.00336	0.036	CbGeAlD
Methylergometrine—HTR2A—vagus nerve—epilepsy syndrome	0.00315	0.0338	CbGeAlD
Methylergometrine—DRD1—ganglion—epilepsy syndrome	0.00312	0.0334	CbGeAlD
Methylergometrine—HTR1F—forebrain—epilepsy syndrome	0.00259	0.0277	CbGeAlD
Methylergometrine—HTR2C—ganglion—epilepsy syndrome	0.00242	0.026	CbGeAlD
Methylergometrine—HTR1F—telencephalon—epilepsy syndrome	0.00238	0.0255	CbGeAlD
Methylergometrine—HTR2A—pons—epilepsy syndrome	0.00237	0.0254	CbGeAlD
Methylergometrine—HTR1E—brainstem—epilepsy syndrome	0.00232	0.0249	CbGeAlD
Methylergometrine—HTR1E—forebrain—epilepsy syndrome	0.00224	0.024	CbGeAlD
Methylergometrine—HTR2A—autonomic nervous system—epilepsy syndrome	0.00219	0.0234	CbGeAlD
Methylergometrine—HTR1E—telencephalon—epilepsy syndrome	0.00206	0.0221	CbGeAlD
Methylergometrine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00195	0.0209	CbGeAlD
Methylergometrine—HTR1F—head—epilepsy syndrome	0.00148	0.0159	CbGeAlD
Methylergometrine—HTR1F—nervous system—epilepsy syndrome	0.00141	0.0151	CbGeAlD
Methylergometrine—DRD1—brainstem—epilepsy syndrome	0.00136	0.0145	CbGeAlD
Methylergometrine—HTR1F—central nervous system—epilepsy syndrome	0.00135	0.0145	CbGeAlD
Methylergometrine—DRD1—forebrain—epilepsy syndrome	0.00131	0.014	CbGeAlD
Methylergometrine—HTR1E—head—epilepsy syndrome	0.00128	0.0138	CbGeAlD
Methylergometrine—HTR1E—nervous system—epilepsy syndrome	0.00122	0.013	CbGeAlD
Methylergometrine—HTR2A—ganglion—epilepsy syndrome	0.00122	0.013	CbGeAlD
Methylergometrine—DRD1—telencephalon—epilepsy syndrome	0.0012	0.0129	CbGeAlD
Methylergometrine—HTR1E—central nervous system—epilepsy syndrome	0.00117	0.0126	CbGeAlD
Methylergometrine—HTR1F—brain—epilepsy syndrome	0.00107	0.0115	CbGeAlD
Methylergometrine—HTR2C—brainstem—epilepsy syndrome	0.00105	0.0113	CbGeAlD
Methylergometrine—HTR2C—forebrain—epilepsy syndrome	0.00102	0.0109	CbGeAlD
Methylergometrine—HTR2B—forebrain—epilepsy syndrome	0.000956	0.0102	CbGeAlD
Methylergometrine—HTR2C—telencephalon—epilepsy syndrome	0.000935	0.01	CbGeAlD
Methylergometrine—HTR1E—brain—epilepsy syndrome	0.000931	0.00997	CbGeAlD
Methylergometrine—HTR2A—hindbrain—epilepsy syndrome	0.000922	0.00988	CbGeAlD
Methylergometrine—HTR2B—telencephalon—epilepsy syndrome	0.000879	0.00941	CbGeAlD
Methylergometrine—DRD1—midbrain—epilepsy syndrome	0.000865	0.00926	CbGeAlD
Methylergometrine—DRD1—head—epilepsy syndrome	0.00075	0.00803	CbGeAlD
Methylergometrine—HTR2C—medulla oblongata—epilepsy syndrome	0.000735	0.00787	CbGeAlD
Methylergometrine—DRD1—nervous system—epilepsy syndrome	0.000711	0.00761	CbGeAlD
Methylergometrine—DRD1—central nervous system—epilepsy syndrome	0.000684	0.00733	CbGeAlD
Methylergometrine—HTR2C—midbrain—epilepsy syndrome	0.000672	0.00719	CbGeAlD
Methylergometrine—HTR2C—spinal cord—epilepsy syndrome	0.000655	0.00702	CbGeAlD
Methylergometrine—Methysergide—HTR7—epilepsy syndrome	0.000587	0.119	CrCbGaD
Methylergometrine—HTR2C—head—epilepsy syndrome	0.000582	0.00624	CbGeAlD
Methylergometrine—HTR2C—nervous system—epilepsy syndrome	0.000552	0.00591	CbGeAlD
Methylergometrine—HTR2B—head—epilepsy syndrome	0.000547	0.00586	CbGeAlD
Methylergometrine—DRD1—brain—epilepsy syndrome	0.000543	0.00582	CbGeAlD
Methylergometrine—HTR2C—central nervous system—epilepsy syndrome	0.000532	0.00569	CbGeAlD
Methylergometrine—HTR2A—brainstem—epilepsy syndrome	0.000529	0.00566	CbGeAlD
Methylergometrine—HTR2B—nervous system—epilepsy syndrome	0.000519	0.00555	CbGeAlD
Methylergometrine—HTR2A—forebrain—epilepsy syndrome	0.00051	0.00546	CbGeAlD
Methylergometrine—HTR2B—central nervous system—epilepsy syndrome	0.000499	0.00535	CbGeAlD
Methylergometrine—HTR2A—telencephalon—epilepsy syndrome	0.000469	0.00502	CbGeAlD
Methylergometrine—Pergolide—ADRA2A—epilepsy syndrome	0.000466	0.0945	CrCbGaD
Methylergometrine—Bromocriptine—HTR7—epilepsy syndrome	0.000437	0.0886	CrCbGaD
Methylergometrine—HTR2C—brain—epilepsy syndrome	0.000422	0.00452	CbGeAlD
Methylergometrine—Lisuride—ADRA2A—epilepsy syndrome	0.000404	0.082	CrCbGaD
Methylergometrine—HTR2B—brain—epilepsy syndrome	0.000396	0.00425	CbGeAlD
Methylergometrine—Ergotamine—ADRA2A—epilepsy syndrome	0.000388	0.0788	CrCbGaD
Methylergometrine—Bromocriptine—ADRA2A—epilepsy syndrome	0.000375	0.076	CrCbGaD
Methylergometrine—HTR2A—medulla oblongata—epilepsy syndrome	0.000369	0.00395	CbGeAlD
Methylergometrine—HTR2A—midbrain—epilepsy syndrome	0.000337	0.00361	CbGeAlD
Methylergometrine—HTR2A—spinal cord—epilepsy syndrome	0.000329	0.00352	CbGeAlD
Methylergometrine—Abdominal pain—Propofol—epilepsy syndrome	0.000315	0.0017	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.000314	0.0017	CcSEcCtD
Methylergometrine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000314	0.0017	CcSEcCtD
Methylergometrine—Nausea—Rufinamide—epilepsy syndrome	0.000313	0.00169	CcSEcCtD
Methylergometrine—Rash—Lacosamide—epilepsy syndrome	0.000312	0.00169	CcSEcCtD
Methylergometrine—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000312	0.00169	CcSEcCtD
Methylergometrine—Dermatitis—Lacosamide—epilepsy syndrome	0.000312	0.00169	CcSEcCtD
Methylergometrine—Chest pain—Lamotrigine—epilepsy syndrome	0.000311	0.00168	CcSEcCtD
Methylergometrine—Tinnitus—Valproic Acid—epilepsy syndrome	0.000311	0.00168	CcSEcCtD
Methylergometrine—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000311	0.00168	CcSEcCtD
Methylergometrine—Headache—Lacosamide—epilepsy syndrome	0.00031	0.00168	CcSEcCtD
Methylergometrine—Paraesthesia—Felbamate—epilepsy syndrome	0.000309	0.00167	CcSEcCtD
Methylergometrine—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000308	0.00167	CcSEcCtD
Methylergometrine—Dyspnoea—Felbamate—epilepsy syndrome	0.000307	0.00166	CcSEcCtD
Methylergometrine—Bradycardia—Pregabalin—epilepsy syndrome	0.000307	0.00166	CcSEcCtD
Methylergometrine—Vomiting—Clobazam—epilepsy syndrome	0.000306	0.00165	CcSEcCtD
Methylergometrine—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000304	0.00164	CcSEcCtD
Methylergometrine—Hypotension—Clonazepam—epilepsy syndrome	0.000304	0.00164	CcSEcCtD
Methylergometrine—Rash—Clobazam—epilepsy syndrome	0.000303	0.00164	CcSEcCtD
Methylergometrine—Paraesthesia—Zonisamide—epilepsy syndrome	0.000303	0.00164	CcSEcCtD
Methylergometrine—Dermatitis—Clobazam—epilepsy syndrome	0.000303	0.00164	CcSEcCtD
Methylergometrine—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000302	0.00163	CcSEcCtD
Methylergometrine—Hypotension—Phenytoin—epilepsy syndrome	0.000302	0.00163	CcSEcCtD
Methylergometrine—Headache—Clobazam—epilepsy syndrome	0.000301	0.00163	CcSEcCtD
Methylergometrine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000301	0.00163	CcSEcCtD
Methylergometrine—Dyspnoea—Zonisamide—epilepsy syndrome	0.000301	0.00163	CcSEcCtD
Methylergometrine—Hypotension—Oxcarbazepine—epilepsy syndrome	0.0003	0.00162	CcSEcCtD
Methylergometrine—Hallucination—Pregabalin—epilepsy syndrome	0.0003	0.00162	CcSEcCtD
Methylergometrine—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000298	0.00161	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000296	0.0016	CcSEcCtD
Methylergometrine—Methysergide—HTR2A—epilepsy syndrome	0.000295	0.0598	CrCbGaD
Methylergometrine—Nausea—Lacosamide—epilepsy syndrome	0.000294	0.00159	CcSEcCtD
Methylergometrine—Haematuria—Gabapentin—epilepsy syndrome	0.000293	0.00159	CcSEcCtD
Methylergometrine—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000293	0.00158	CcSEcCtD
Methylergometrine—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000292	0.00158	CcSEcCtD
Methylergometrine—HTR2A—head—epilepsy syndrome	0.000292	0.00313	CbGeAlD
Methylergometrine—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000291	0.00157	CcSEcCtD
Methylergometrine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000291	0.00157	CcSEcCtD
Methylergometrine—Paraesthesia—Phenytoin—epilepsy syndrome	0.00029	0.00157	CcSEcCtD
Methylergometrine—Dyspnoea—Clonazepam—epilepsy syndrome	0.00029	0.00157	CcSEcCtD
Methylergometrine—Hypotension—Carbamazepine—epilepsy syndrome	0.000288	0.00156	CcSEcCtD
Methylergometrine—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000288	0.00156	CcSEcCtD
Methylergometrine—Dyspnoea—Phenytoin—epilepsy syndrome	0.000288	0.00156	CcSEcCtD
Methylergometrine—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000286	0.00155	CcSEcCtD
Methylergometrine—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000286	0.00155	CcSEcCtD
Methylergometrine—Nausea—Clobazam—epilepsy syndrome	0.000286	0.00154	CcSEcCtD
Methylergometrine—Dizziness—Acetazolamide—epilepsy syndrome	0.000283	0.00153	CcSEcCtD
Methylergometrine—Angina pectoris—Topiramate—epilepsy syndrome	0.000283	0.00153	CcSEcCtD
Methylergometrine—Sweating increased—Topiramate—epilepsy syndrome	0.000283	0.00153	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000282	0.00152	CcSEcCtD
Methylergometrine—Abdominal pain—Diazepam—epilepsy syndrome	0.000282	0.00152	CcSEcCtD
Methylergometrine—Bradycardia—Gabapentin—epilepsy syndrome	0.000281	0.00152	CcSEcCtD
Methylergometrine—Tinnitus—Pregabalin—epilepsy syndrome	0.000281	0.00152	CcSEcCtD
Methylergometrine—Cardiac disorder—Pregabalin—epilepsy syndrome	0.00028	0.00151	CcSEcCtD
Methylergometrine—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000279	0.00151	CcSEcCtD
Methylergometrine—HTR2A—nervous system—epilepsy syndrome	0.000277	0.00297	CbGeAlD
Methylergometrine—Paraesthesia—Carbamazepine—epilepsy syndrome	0.000277	0.0015	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000276	0.00149	CcSEcCtD
Methylergometrine—Hallucination—Gabapentin—epilepsy syndrome	0.000275	0.00149	CcSEcCtD
Methylergometrine—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000275	0.00149	CcSEcCtD
Methylergometrine—Pergolide—HTR2A—epilepsy syndrome	0.000273	0.0554	CrCbGaD
Methylergometrine—Abdominal pain—Felbamate—epilepsy syndrome	0.000272	0.00147	CcSEcCtD
Methylergometrine—Vomiting—Acetazolamide—epilepsy syndrome	0.000272	0.00147	CcSEcCtD
Methylergometrine—Diarrhoea—Propofol—epilepsy syndrome	0.000272	0.00147	CcSEcCtD
Methylergometrine—Headache—Acetazolamide—epilepsy syndrome	0.000268	0.00145	CcSEcCtD
Methylergometrine—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000268	0.00145	CcSEcCtD
Methylergometrine—Abdominal pain—Zonisamide—epilepsy syndrome	0.000267	0.00144	CcSEcCtD
Methylergometrine—HTR2A—central nervous system—epilepsy syndrome	0.000267	0.00286	CbGeAlD
Methylergometrine—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000266	0.00144	CcSEcCtD
Methylergometrine—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000266	0.00144	CcSEcCtD
Methylergometrine—Ergonovine—ABCB1—epilepsy syndrome	0.000264	0.0535	CrCbGaD
Methylergometrine—Dizziness—Propofol—epilepsy syndrome	0.000263	0.00142	CcSEcCtD
Methylergometrine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000263	0.00142	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000263	0.00142	CcSEcCtD
Methylergometrine—HTR2A—cerebellum—epilepsy syndrome	0.000261	0.00279	CbGeAlD
Methylergometrine—Tinnitus—Gabapentin—epilepsy syndrome	0.000258	0.00139	CcSEcCtD
Methylergometrine—Dizziness—Midazolam—epilepsy syndrome	0.000257	0.00139	CcSEcCtD
Methylergometrine—Abdominal pain—Clonazepam—epilepsy syndrome	0.000257	0.00139	CcSEcCtD
Methylergometrine—CYP3A4—nervous system—epilepsy syndrome	0.000256	0.00275	CbGeAlD
Methylergometrine—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000256	0.00139	CcSEcCtD
Methylergometrine—Palpitations—Valproic Acid—epilepsy syndrome	0.000256	0.00139	CcSEcCtD
Methylergometrine—Nausea—Acetazolamide—epilepsy syndrome	0.000254	0.00138	CcSEcCtD
Methylergometrine—Dizziness—Levetiracetam—epilepsy syndrome	0.000254	0.00137	CcSEcCtD
Methylergometrine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000254	0.00137	CcSEcCtD
Methylergometrine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000254	0.00137	CcSEcCtD
Methylergometrine—Vomiting—Propofol—epilepsy syndrome	0.000253	0.00137	CcSEcCtD
Methylergometrine—Muscle spasms—Pregabalin—epilepsy syndrome	0.000252	0.00136	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000252	0.00136	CcSEcCtD
Methylergometrine—Rash—Propofol—epilepsy syndrome	0.000251	0.00136	CcSEcCtD
Methylergometrine—Dermatitis—Propofol—epilepsy syndrome	0.000251	0.00136	CcSEcCtD
Methylergometrine—Hypertension—Valproic Acid—epilepsy syndrome	0.00025	0.00135	CcSEcCtD
Methylergometrine—Pergolide—CYP2D6—epilepsy syndrome	0.00025	0.0506	CrCbGaD
Methylergometrine—Headache—Propofol—epilepsy syndrome	0.000249	0.00135	CcSEcCtD
Methylergometrine—Vomiting—Midazolam—epilepsy syndrome	0.000248	0.00134	CcSEcCtD
Methylergometrine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000247	0.00134	CcSEcCtD
Methylergometrine—Chest pain—Valproic Acid—epilepsy syndrome	0.000247	0.00134	CcSEcCtD
Methylergometrine—CYP3A4—central nervous system—epilepsy syndrome	0.000247	0.00264	CbGeAlD
Methylergometrine—Haematuria—Topiramate—epilepsy syndrome	0.000247	0.00133	CcSEcCtD
Methylergometrine—Rash—Midazolam—epilepsy syndrome	0.000245	0.00133	CcSEcCtD
Methylergometrine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000245	0.00133	CcSEcCtD
Methylergometrine—Dermatitis—Midazolam—epilepsy syndrome	0.000245	0.00133	CcSEcCtD
Methylergometrine—Vomiting—Levetiracetam—epilepsy syndrome	0.000244	0.00132	CcSEcCtD
Methylergometrine—Headache—Midazolam—epilepsy syndrome	0.000244	0.00132	CcSEcCtD
Methylergometrine—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000244	0.00132	CcSEcCtD
Methylergometrine—Diarrhoea—Diazepam—epilepsy syndrome	0.000244	0.00132	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000244	0.00132	CcSEcCtD
Methylergometrine—Rash—Levetiracetam—epilepsy syndrome	0.000242	0.00131	CcSEcCtD
Methylergometrine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000242	0.00131	CcSEcCtD
Methylergometrine—Headache—Levetiracetam—epilepsy syndrome	0.000241	0.0013	CcSEcCtD
Methylergometrine—Dizziness—Vigabatrin—epilepsy syndrome	0.000239	0.00129	CcSEcCtD
Methylergometrine—Lisuride—HTR2A—epilepsy syndrome	0.000237	0.0481	CrCbGaD
Methylergometrine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000237	0.00128	CcSEcCtD
Methylergometrine—Bradycardia—Topiramate—epilepsy syndrome	0.000237	0.00128	CcSEcCtD
Methylergometrine—Nausea—Propofol—epilepsy syndrome	0.000236	0.00128	CcSEcCtD
Methylergometrine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000236	0.00128	CcSEcCtD
Methylergometrine—Diarrhoea—Felbamate—epilepsy syndrome	0.000236	0.00127	CcSEcCtD
Methylergometrine—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000236	0.00127	CcSEcCtD
Methylergometrine—Dizziness—Diazepam—epilepsy syndrome	0.000235	0.00127	CcSEcCtD
Methylergometrine—Rash—Fosphenytoin—epilepsy syndrome	0.000234	0.00127	CcSEcCtD
Methylergometrine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000234	0.00126	CcSEcCtD
Methylergometrine—Headache—Fosphenytoin—epilepsy syndrome	0.000232	0.00126	CcSEcCtD
Methylergometrine—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000232	0.00126	CcSEcCtD
Methylergometrine—Palpitations—Pregabalin—epilepsy syndrome	0.000232	0.00125	CcSEcCtD
Methylergometrine—Nausea—Midazolam—epilepsy syndrome	0.000231	0.00125	CcSEcCtD
Methylergometrine—Hallucination—Topiramate—epilepsy syndrome	0.000231	0.00125	CcSEcCtD
Methylergometrine—Muscle spasms—Gabapentin—epilepsy syndrome	0.000231	0.00125	CcSEcCtD
Methylergometrine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000231	0.00125	CcSEcCtD
Methylergometrine—Diarrhoea—Zonisamide—epilepsy syndrome	0.000231	0.00125	CcSEcCtD
Methylergometrine—Vomiting—Vigabatrin—epilepsy syndrome	0.00023	0.00124	CcSEcCtD
Methylergometrine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000229	0.00124	CcSEcCtD
Methylergometrine—Nausea—Levetiracetam—epilepsy syndrome	0.000228	0.00123	CcSEcCtD
Methylergometrine—Rash—Vigabatrin—epilepsy syndrome	0.000228	0.00123	CcSEcCtD
Methylergometrine—Dizziness—Felbamate—epilepsy syndrome	0.000228	0.00123	CcSEcCtD
Methylergometrine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000228	0.00123	CcSEcCtD
Methylergometrine—Ergotamine—HTR2A—epilepsy syndrome	0.000228	0.0462	CrCbGaD
Methylergometrine—Convulsion—Pregabalin—epilepsy syndrome	0.000227	0.00123	CcSEcCtD
Methylergometrine—Headache—Vigabatrin—epilepsy syndrome	0.000227	0.00123	CcSEcCtD
Methylergometrine—Hypertension—Pregabalin—epilepsy syndrome	0.000226	0.00122	CcSEcCtD
Methylergometrine—Vomiting—Diazepam—epilepsy syndrome	0.000226	0.00122	CcSEcCtD
Methylergometrine—Rash—Diazepam—epilepsy syndrome	0.000225	0.00121	CcSEcCtD
Methylergometrine—Dermatitis—Diazepam—epilepsy syndrome	0.000224	0.00121	CcSEcCtD
Methylergometrine—Chest pain—Pregabalin—epilepsy syndrome	0.000223	0.00121	CcSEcCtD
Methylergometrine—Dizziness—Zonisamide—epilepsy syndrome	0.000223	0.00121	CcSEcCtD
Methylergometrine—Headache—Diazepam—epilepsy syndrome	0.000223	0.00121	CcSEcCtD
Methylergometrine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000222	0.0012	CcSEcCtD
Methylergometrine—Hypotension—Valproic Acid—epilepsy syndrome	0.000221	0.0012	CcSEcCtD
Methylergometrine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000221	0.00119	CcSEcCtD
Methylergometrine—Nausea—Fosphenytoin—epilepsy syndrome	0.00022	0.00119	CcSEcCtD
Methylergometrine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00022	0.00119	CcSEcCtD
Methylergometrine—Bromocriptine—HTR2A—epilepsy syndrome	0.00022	0.0445	CrCbGaD
Methylergometrine—Vomiting—Felbamate—epilepsy syndrome	0.000219	0.00118	CcSEcCtD
Methylergometrine—Rash—Felbamate—epilepsy syndrome	0.000217	0.00117	CcSEcCtD
Methylergometrine—Dermatitis—Felbamate—epilepsy syndrome	0.000217	0.00117	CcSEcCtD
Methylergometrine—Lisuride—CYP2D6—epilepsy syndrome	0.000217	0.044	CrCbGaD
Methylergometrine—Tinnitus—Topiramate—epilepsy syndrome	0.000217	0.00117	CcSEcCtD
Methylergometrine—Headache—Felbamate—epilepsy syndrome	0.000216	0.00117	CcSEcCtD
Methylergometrine—Cardiac disorder—Topiramate—epilepsy syndrome	0.000216	0.00117	CcSEcCtD
Methylergometrine—Dizziness—Clonazepam—epilepsy syndrome	0.000215	0.00116	CcSEcCtD
Methylergometrine—Nausea—Vigabatrin—epilepsy syndrome	0.000215	0.00116	CcSEcCtD
Methylergometrine—Vomiting—Zonisamide—epilepsy syndrome	0.000215	0.00116	CcSEcCtD
Methylergometrine—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000214	0.00116	CcSEcCtD
Methylergometrine—Dizziness—Phenytoin—epilepsy syndrome	0.000214	0.00115	CcSEcCtD
Methylergometrine—Rash—Zonisamide—epilepsy syndrome	0.000213	0.00115	CcSEcCtD
Methylergometrine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000213	0.00115	CcSEcCtD
Methylergometrine—Palpitations—Gabapentin—epilepsy syndrome	0.000213	0.00115	CcSEcCtD
Methylergometrine—Dermatitis—Zonisamide—epilepsy syndrome	0.000213	0.00115	CcSEcCtD
Methylergometrine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000212	0.00115	CcSEcCtD
Methylergometrine—HTR2A—brain—epilepsy syndrome	0.000212	0.00227	CbGeAlD
Methylergometrine—Nausea—Diazepam—epilepsy syndrome	0.000212	0.00114	CcSEcCtD
Methylergometrine—Headache—Zonisamide—epilepsy syndrome	0.000211	0.00114	CcSEcCtD
Methylergometrine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000211	0.00114	CcSEcCtD
Methylergometrine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000211	0.00114	CcSEcCtD
Methylergometrine—Nervous system disorder—Pregabalin—epilepsy syndrome	0.00021	0.00113	CcSEcCtD
Methylergometrine—Tachycardia—Pregabalin—epilepsy syndrome	0.000209	0.00113	CcSEcCtD
Methylergometrine—Convulsion—Gabapentin—epilepsy syndrome	0.000208	0.00113	CcSEcCtD
Methylergometrine—Hypertension—Gabapentin—epilepsy syndrome	0.000208	0.00112	CcSEcCtD
Methylergometrine—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000207	0.00112	CcSEcCtD
Methylergometrine—Vomiting—Clonazepam—epilepsy syndrome	0.000207	0.00112	CcSEcCtD
Methylergometrine—Vomiting—Phenytoin—epilepsy syndrome	0.000205	0.00111	CcSEcCtD
Methylergometrine—Rash—Clonazepam—epilepsy syndrome	0.000205	0.00111	CcSEcCtD
Methylergometrine—Dermatitis—Clonazepam—epilepsy syndrome	0.000205	0.00111	CcSEcCtD
Methylergometrine—Chest pain—Gabapentin—epilepsy syndrome	0.000205	0.00111	CcSEcCtD
Methylergometrine—Nausea—Felbamate—epilepsy syndrome	0.000205	0.00111	CcSEcCtD
Methylergometrine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000204	0.0011	CcSEcCtD
Methylergometrine—Dizziness—Carbamazepine—epilepsy syndrome	0.000204	0.0011	CcSEcCtD
Methylergometrine—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000204	0.0011	CcSEcCtD
Methylergometrine—Headache—Clonazepam—epilepsy syndrome	0.000204	0.0011	CcSEcCtD
Methylergometrine—Rash—Phenytoin—epilepsy syndrome	0.000204	0.0011	CcSEcCtD
Methylergometrine—Dermatitis—Phenytoin—epilepsy syndrome	0.000203	0.0011	CcSEcCtD
Methylergometrine—Rash—Oxcarbazepine—epilepsy syndrome	0.000203	0.0011	CcSEcCtD
Methylergometrine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000202	0.00109	CcSEcCtD
Methylergometrine—Headache—Phenytoin—epilepsy syndrome	0.000202	0.00109	CcSEcCtD
Methylergometrine—Headache—Oxcarbazepine—epilepsy syndrome	0.000201	0.00109	CcSEcCtD
Methylergometrine—Nausea—Zonisamide—epilepsy syndrome	0.0002	0.00108	CcSEcCtD
Methylergometrine—Hypotension—Pregabalin—epilepsy syndrome	0.0002	0.00108	CcSEcCtD
Methylergometrine—Dizziness—Lamotrigine—epilepsy syndrome	0.000197	0.00107	CcSEcCtD
Methylergometrine—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000196	0.00106	CcSEcCtD
Methylergometrine—Vomiting—Carbamazepine—epilepsy syndrome	0.000196	0.00106	CcSEcCtD
Methylergometrine—Muscle spasms—Topiramate—epilepsy syndrome	0.000195	0.00105	CcSEcCtD
Methylergometrine—Rash—Carbamazepine—epilepsy syndrome	0.000194	0.00105	CcSEcCtD
Methylergometrine—Dermatitis—Carbamazepine—epilepsy syndrome	0.000194	0.00105	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000194	0.00105	CcSEcCtD
Methylergometrine—Nausea—Clonazepam—epilepsy syndrome	0.000193	0.00104	CcSEcCtD
Methylergometrine—Headache—Carbamazepine—epilepsy syndrome	0.000193	0.00104	CcSEcCtD
Methylergometrine—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000192	0.00104	CcSEcCtD
Methylergometrine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000192	0.00104	CcSEcCtD
Methylergometrine—Nausea—Phenytoin—epilepsy syndrome	0.000192	0.00104	CcSEcCtD
Methylergometrine—Tachycardia—Gabapentin—epilepsy syndrome	0.000192	0.00104	CcSEcCtD
Methylergometrine—Dyspnoea—Pregabalin—epilepsy syndrome	0.000191	0.00103	CcSEcCtD
Methylergometrine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000191	0.00103	CcSEcCtD
Methylergometrine—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.00019	0.00103	CcSEcCtD
Methylergometrine—Vomiting—Lamotrigine—epilepsy syndrome	0.000189	0.00102	CcSEcCtD
Methylergometrine—Rash—Lamotrigine—epilepsy syndrome	0.000188	0.00102	CcSEcCtD
Methylergometrine—Dermatitis—Lamotrigine—epilepsy syndrome	0.000188	0.00101	CcSEcCtD
Methylergometrine—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000187	0.00101	CcSEcCtD
Methylergometrine—Headache—Lamotrigine—epilepsy syndrome	0.000187	0.00101	CcSEcCtD
Methylergometrine—Hypotension—Gabapentin—epilepsy syndrome	0.000183	0.000992	CcSEcCtD
Methylergometrine—Nausea—Carbamazepine—epilepsy syndrome	0.000183	0.00099	CcSEcCtD
Methylergometrine—Palpitations—Topiramate—epilepsy syndrome	0.000179	0.000967	CcSEcCtD
Methylergometrine—Nausea—Lamotrigine—epilepsy syndrome	0.000177	0.000957	CcSEcCtD
Methylergometrine—Paraesthesia—Gabapentin—epilepsy syndrome	0.000176	0.000953	CcSEcCtD
Methylergometrine—Convulsion—Topiramate—epilepsy syndrome	0.000175	0.000948	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000175	0.000946	CcSEcCtD
Methylergometrine—Dyspnoea—Gabapentin—epilepsy syndrome	0.000175	0.000946	CcSEcCtD
Methylergometrine—Hypertension—Topiramate—epilepsy syndrome	0.000175	0.000944	CcSEcCtD
Methylergometrine—Chest pain—Topiramate—epilepsy syndrome	0.000172	0.000931	CcSEcCtD
Methylergometrine—Abdominal pain—Pregabalin—epilepsy syndrome	0.000169	0.000915	CcSEcCtD
Methylergometrine—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000162	0.000876	CcSEcCtD
Methylergometrine—Nervous system disorder—Topiramate—epilepsy syndrome	0.000162	0.000876	CcSEcCtD
Methylergometrine—Tachycardia—Topiramate—epilepsy syndrome	0.000161	0.000871	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00016	0.000868	CcSEcCtD
Methylergometrine—Hyperhidrosis—Topiramate—epilepsy syndrome	0.00016	0.000863	CcSEcCtD
Methylergometrine—Dizziness—Valproic Acid—epilepsy syndrome	0.000157	0.000846	CcSEcCtD
Methylergometrine—Abdominal pain—Gabapentin—epilepsy syndrome	0.000155	0.000839	CcSEcCtD
Methylergometrine—Hypotension—Topiramate—epilepsy syndrome	0.000154	0.000834	CcSEcCtD
Methylergometrine—Vomiting—Valproic Acid—epilepsy syndrome	0.000151	0.000814	CcSEcCtD
Methylergometrine—Rash—Valproic Acid—epilepsy syndrome	0.000149	0.000807	CcSEcCtD
Methylergometrine—Dermatitis—Valproic Acid—epilepsy syndrome	0.000149	0.000806	CcSEcCtD
Methylergometrine—Ergotamine—ABCB1—epilepsy syndrome	0.000149	0.0302	CrCbGaD
Methylergometrine—Headache—Valproic Acid—epilepsy syndrome	0.000148	0.000802	CcSEcCtD
Methylergometrine—Paraesthesia—Topiramate—epilepsy syndrome	0.000148	0.000802	CcSEcCtD
Methylergometrine—Dyspnoea—Topiramate—epilepsy syndrome	0.000147	0.000796	CcSEcCtD
Methylergometrine—Diarrhoea—Pregabalin—epilepsy syndrome	0.000146	0.000792	CcSEcCtD
Methylergometrine—Bromocriptine—ABCB1—epilepsy syndrome	0.000143	0.0291	CrCbGaD
Methylergometrine—Dizziness—Pregabalin—epilepsy syndrome	0.000142	0.000765	CcSEcCtD
Methylergometrine—Nausea—Valproic Acid—epilepsy syndrome	0.000141	0.00076	CcSEcCtD
Methylergometrine—Vomiting—Pregabalin—epilepsy syndrome	0.000136	0.000736	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000135	0.00073	CcSEcCtD
Methylergometrine—Rash—Pregabalin—epilepsy syndrome	0.000135	0.00073	CcSEcCtD
Methylergometrine—Dermatitis—Pregabalin—epilepsy syndrome	0.000135	0.000729	CcSEcCtD
Methylergometrine—Diarrhoea—Gabapentin—epilepsy syndrome	0.000134	0.000726	CcSEcCtD
Methylergometrine—Headache—Pregabalin—epilepsy syndrome	0.000134	0.000725	CcSEcCtD
Methylergometrine—Abdominal pain—Topiramate—epilepsy syndrome	0.000131	0.000706	CcSEcCtD
Methylergometrine—Dizziness—Gabapentin—epilepsy syndrome	0.00013	0.000702	CcSEcCtD
Methylergometrine—Nausea—Pregabalin—epilepsy syndrome	0.000127	0.000687	CcSEcCtD
Methylergometrine—Vomiting—Gabapentin—epilepsy syndrome	0.000125	0.000675	CcSEcCtD
Methylergometrine—Rash—Gabapentin—epilepsy syndrome	0.000124	0.000669	CcSEcCtD
Methylergometrine—Dermatitis—Gabapentin—epilepsy syndrome	0.000124	0.000668	CcSEcCtD
Methylergometrine—Headache—Gabapentin—epilepsy syndrome	0.000123	0.000665	CcSEcCtD
Methylergometrine—Nausea—Gabapentin—epilepsy syndrome	0.000117	0.00063	CcSEcCtD
Methylergometrine—Diarrhoea—Topiramate—epilepsy syndrome	0.000113	0.000611	CcSEcCtD
Methylergometrine—Dizziness—Topiramate—epilepsy syndrome	0.000109	0.00059	CcSEcCtD
Methylergometrine—Vomiting—Topiramate—epilepsy syndrome	0.000105	0.000568	CcSEcCtD
Methylergometrine—Rash—Topiramate—epilepsy syndrome	0.000104	0.000563	CcSEcCtD
Methylergometrine—Dermatitis—Topiramate—epilepsy syndrome	0.000104	0.000562	CcSEcCtD
Methylergometrine—Headache—Topiramate—epilepsy syndrome	0.000103	0.000559	CcSEcCtD
Methylergometrine—Nausea—Topiramate—epilepsy syndrome	9.81e-05	0.00053	CcSEcCtD
Methylergometrine—HTR2B—Signaling by GPCR—CCL2—epilepsy syndrome	1e-05	6.68e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.99e-06	6.66e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TSC1—epilepsy syndrome	9.97e-06	6.64e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTK2B—epilepsy syndrome	9.97e-06	6.64e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HBEGF—epilepsy syndrome	9.9e-06	6.6e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR3—epilepsy syndrome	9.9e-06	6.6e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AGT—epilepsy syndrome	9.82e-06	6.55e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT3—epilepsy syndrome	9.72e-06	6.48e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—POMC—epilepsy syndrome	9.7e-06	6.47e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NTRK2—epilepsy syndrome	9.69e-06	6.46e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR2—epilepsy syndrome	9.69e-06	6.46e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SST—epilepsy syndrome	9.69e-06	6.46e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—POMC—epilepsy syndrome	9.66e-06	6.44e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NPY—epilepsy syndrome	9.65e-06	6.43e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ATP2A2—epilepsy syndrome	9.65e-06	6.43e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DUSP6—epilepsy syndrome	9.61e-06	6.41e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—S100B—epilepsy syndrome	9.52e-06	6.35e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCL2—epilepsy syndrome	9.5e-06	6.33e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADAM10—epilepsy syndrome	9.5e-06	6.33e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRA2A—epilepsy syndrome	9.49e-06	6.32e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCL2—epilepsy syndrome	9.45e-06	6.3e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PLAT—epilepsy syndrome	9.45e-06	6.3e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SOCS3—epilepsy syndrome	9.43e-06	6.29e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDC42—epilepsy syndrome	9.41e-06	6.27e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.4e-06	6.26e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.4e-06	6.26e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.4e-06	6.26e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AGT—epilepsy syndrome	9.39e-06	6.26e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HSPB1—epilepsy syndrome	9.31e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL3—epilepsy syndrome	9.31e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—OXT—epilepsy syndrome	9.31e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CRH—epilepsy syndrome	9.31e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL2—epilepsy syndrome	9.31e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR5—epilepsy syndrome	9.18e-06	6.12e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BDKRB2—epilepsy syndrome	9.11e-06	6.08e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL12—epilepsy syndrome	9.11e-06	6.08e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AVP—epilepsy syndrome	9.11e-06	6.07e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—POMC—epilepsy syndrome	9.1e-06	6.07e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—FGF2—epilepsy syndrome	9.1e-06	6.06e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PRKCB—epilepsy syndrome	9.07e-06	6.05e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.05e-06	6.03e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6ST—epilepsy syndrome	9.04e-06	6.02e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—S100B—epilepsy syndrome	8.98e-06	5.99e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—JUNB—epilepsy syndrome	8.95e-06	5.96e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CNR1—epilepsy syndrome	8.95e-06	5.96e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PLCB1—epilepsy syndrome	8.91e-06	5.94e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SOCS3—epilepsy syndrome	8.89e-06	5.93e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDC42—epilepsy syndrome	8.87e-06	5.91e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	8.74e-06	5.82e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	8.74e-06	5.82e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR7—epilepsy syndrome	8.73e-06	5.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.68e-06	5.78e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TSC1—epilepsy syndrome	8.65e-06	5.77e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTK2B—epilepsy syndrome	8.65e-06	5.77e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HES1—epilepsy syndrome	8.61e-06	5.74e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AVP—epilepsy syndrome	8.59e-06	5.72e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—FGF2—epilepsy syndrome	8.58e-06	5.72e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AGT—epilepsy syndrome	8.53e-06	5.68e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HBEGF—epilepsy syndrome	8.47e-06	5.65e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RELA—epilepsy syndrome	8.45e-06	5.63e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SST—epilepsy syndrome	8.42e-06	5.61e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR2—epilepsy syndrome	8.42e-06	5.61e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NTRK2—epilepsy syndrome	8.42e-06	5.61e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FYN—epilepsy syndrome	8.37e-06	5.58e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DUSP6—epilepsy syndrome	8.34e-06	5.56e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—H2AFX—epilepsy syndrome	8.34e-06	5.56e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MEF2C—epilepsy syndrome	8.33e-06	5.55e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT3—epilepsy syndrome	8.32e-06	5.54e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MTOR—epilepsy syndrome	8.28e-06	5.52e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—POMC—epilepsy syndrome	8.26e-06	5.51e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRA2A—epilepsy syndrome	8.24e-06	5.49e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.21e-06	5.48e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PLAT—epilepsy syndrome	8.2e-06	5.47e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADAM10—epilepsy syndrome	8.12e-06	5.42e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HES1—epilepsy syndrome	8.12e-06	5.41e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCL2—epilepsy syndrome	8.09e-06	5.39e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—YWHAZ—epilepsy syndrome	8.05e-06	5.37e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.99e-06	5.33e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RELA—epilepsy syndrome	7.97e-06	5.31e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NGF—epilepsy syndrome	7.96e-06	5.31e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BDKRB2—epilepsy syndrome	7.91e-06	5.28e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL12—epilepsy syndrome	7.91e-06	5.28e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—POMC—epilepsy syndrome	7.9e-06	5.27e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FYN—epilepsy syndrome	7.9e-06	5.26e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PRKCB—epilepsy syndrome	7.88e-06	5.25e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—H2AFX—epilepsy syndrome	7.87e-06	5.25e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MEF2C—epilepsy syndrome	7.85e-06	5.24e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6ST—epilepsy syndrome	7.85e-06	5.23e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MTOR—epilepsy syndrome	7.81e-06	5.21e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.79e-06	5.19e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.79e-06	5.19e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—JUNB—epilepsy syndrome	7.77e-06	5.18e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CNR1—epilepsy syndrome	7.77e-06	5.18e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	7.74e-06	5.16e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	7.74e-06	5.16e-05	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AKT1—epilepsy syndrome	7.69e-06	5.13e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—S100B—epilepsy syndrome	7.68e-06	5.12e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CASP3—epilepsy syndrome	7.62e-06	5.08e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SOCS3—epilepsy syndrome	7.61e-06	5.07e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.59e-06	5.06e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDC42—epilepsy syndrome	7.59e-06	5.06e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	7.58e-06	5.05e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	7.58e-06	5.05e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NGF—epilepsy syndrome	7.51e-06	5e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.43e-06	4.95e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.43e-06	4.95e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—JUN—epilepsy syndrome	7.4e-06	4.93e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	7.36e-06	4.91e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	7.35e-06	4.9e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR5—epilepsy syndrome	7.3e-06	4.87e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.27e-06	4.85e-05	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AKT1—epilepsy syndrome	7.25e-06	4.83e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	7.22e-06	4.81e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MMP9—epilepsy syndrome	7.2e-06	4.8e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	7.2e-06	4.8e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	7.19e-06	4.79e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CASP3—epilepsy syndrome	7.19e-06	4.79e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	7.18e-06	4.78e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR2A—epilepsy syndrome	7.15e-06	4.76e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.12e-06	4.75e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	7.05e-06	4.7e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	7.04e-06	4.7e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	7.02e-06	4.68e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.98e-06	4.66e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AKT1—epilepsy syndrome	6.98e-06	4.65e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—JUN—epilepsy syndrome	6.98e-06	4.65e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	6.95e-06	4.63e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	6.9e-06	4.6e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.86e-06	4.57e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MMP9—epilepsy syndrome	6.79e-06	4.53e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TSC2—epilepsy syndrome	6.79e-06	4.53e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AGT—epilepsy syndrome	6.78e-06	4.52e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	6.76e-06	4.5e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	6.73e-06	4.49e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	6.72e-06	4.48e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	6.67e-06	4.45e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APOE—epilepsy syndrome	6.64e-06	4.43e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	6.64e-06	4.43e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SRC—epilepsy syndrome	6.64e-06	4.42e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	6.62e-06	4.41e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	6.61e-06	4.4e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	6.59e-06	4.39e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AKT1—epilepsy syndrome	6.59e-06	4.39e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KDR—epilepsy syndrome	6.51e-06	4.34e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	6.49e-06	4.33e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—epilepsy syndrome	6.46e-06	4.31e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	6.42e-06	4.28e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.41e-06	4.27e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	6.38e-06	4.25e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PRKCB—epilepsy syndrome	6.26e-06	4.18e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SRC—epilepsy syndrome	6.26e-06	4.17e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	6.25e-06	4.16e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6ST—epilepsy syndrome	6.24e-06	4.16e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.22e-06	4.15e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	6.11e-06	4.08e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—epilepsy syndrome	6.1e-06	4.06e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	6.05e-06	4.03e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	6.03e-06	4.02e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	5.92e-06	3.95e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	5.87e-06	3.91e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	5.85e-06	3.9e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	5.83e-06	3.89e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	5.81e-06	3.87e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	5.8e-06	3.87e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—POMC—epilepsy syndrome	5.71e-06	3.8e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	5.68e-06	3.79e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.64e-06	3.76e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.63e-06	3.75e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.63e-06	3.75e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	5.58e-06	3.72e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	5.58e-06	3.72e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	5.57e-06	3.71e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	5.42e-06	3.62e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	5.36e-06	3.57e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	5.35e-06	3.57e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	5.34e-06	3.56e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	5.05e-06	3.36e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	5.04e-06	3.36e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	5.04e-06	3.36e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	4.97e-06	3.31e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	4.94e-06	3.29e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	4.88e-06	3.25e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	4.87e-06	3.25e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	4.83e-06	3.22e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	4.78e-06	3.18e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RELA—epilepsy syndrome	4.68e-06	3.12e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.65e-06	3.1e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.64e-06	3.09e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	4.59e-06	3.06e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.59e-06	3.06e-05	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.52e-06	3.01e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	4.48e-06	2.99e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.47e-06	2.98e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.44e-06	2.96e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	4.35e-06	2.9e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	4.32e-06	2.88e-05	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.26e-06	2.84e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	4.24e-06	2.83e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	4.23e-06	2.82e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	4.23e-06	2.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	4.15e-06	2.77e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	4.12e-06	2.75e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.11e-06	2.74e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	4.1e-06	2.74e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.01e-06	2.67e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	4.01e-06	2.67e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	3.99e-06	2.66e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	3.93e-06	2.62e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	3.9e-06	2.6e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	3.89e-06	2.59e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	3.87e-06	2.58e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.82e-06	2.55e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.8e-06	2.53e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.8e-06	2.53e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	3.75e-06	2.5e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	3.68e-06	2.45e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.65e-06	2.43e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.63e-06	2.42e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	3.61e-06	2.41e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.59e-06	2.39e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	3.59e-06	2.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TH—epilepsy syndrome	3.58e-06	2.38e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	3.51e-06	2.34e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	3.48e-06	2.32e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.42e-06	2.28e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.41e-06	2.28e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.31e-06	2.21e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.17e-06	2.11e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	3.15e-06	2.1e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	3.14e-06	2.09e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.07e-06	2.04e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	3.05e-06	2.03e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.98e-06	1.99e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.97e-06	1.98e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.94e-06	1.96e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.88e-06	1.92e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.86e-06	1.91e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	2.73e-06	1.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.66e-06	1.78e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.66e-06	1.77e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.43e-06	1.62e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.33e-06	1.56e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	2.29e-06	1.53e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.29e-06	1.53e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.97e-06	1.31e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.96e-06	1.3e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.79e-06	1.19e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.7e-06	1.13e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.57e-06	1.04e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.88e-07	5.25e-06	CbGpPWpGaD
